Gau Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 854.58%
- Profit Growth 2712.52%
- Ebitda -11569.77%
- Net Worth 602.44%
- Total Assets 13236.07%
About Gau Life Sciences
Gau Life Sciences Private Limited (GLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2021 (Four years and one month 11 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Darshini Adani and Krishi Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24299GJ2021PTC119248
-
Company No.
119248
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jan 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Gau Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshini Adani
|
Director | 11-Jun-2021 | Current |
|
Krishi Patel
|
Director | 01-Jan-2021 | Current |
Financial Performance of Gau Life Sciences.
Gau Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 854.58% increase. The company also saw a substantial improvement in profitability, with a 2712.52% increase in profit. The company's net worth Soared by an impressive increase of 602.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gau Life Sciences?
Unlock access to Gau Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Adorn Enterprises LimitedDarshini Adani is a mutual person
-
Omg Impact Private Limited
Darshini Adani is a mutual person
-
Om Frozen Products Private Limited
Darshini Adani is a mutual person
-
Omwell Biotech Llp
Krishi Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gau Life Sciences?
Gau Life Sciences has a workforce of 0 employees as of Nov 15, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gau Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gau Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
